Innovent Biologics Inc. (IVBXF)
PNK: IVBXF
· Real-Time Price · USD
5.97
0.00 (0.00%)
At close: Apr 29, 2025, 8:00 PM
Innovent Biologics Revenue
Innovent Biologics reported an annual revenue of $6.21B, reflecting a 36.21% growth. For the quarter ending June 30, 2024, Innovent Biologics generated $3.95B in revenue.
Revenue (ttm)
$6.21B
Revenue Growth
36.21%
Price / Sales Ratio
8.76
Revenue / Employee
$1.1M
Employees
5,659
Market Cap
9.79B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2023 | 6.21B | +36.21% |
| Dec 31, 2022 | 4.56B | +6.71% |
| Dec 31, 2021 | 4.27B | +11.08% |
| Dec 31, 2020 | 3.84B | n/a |